Literature DB >> 15006947

Prevalence of COPD in Greece.

Nikolaos Tzanakis1, Urania Anagnostopoulou, Vassiliki Filaditaki, Pandora Christaki, Nikolaos Siafakas.   

Abstract

OBJECTIVES: The prevalence of COPD in Greece is unknown. The aim of this study was to determine the prevalence and trends of COPD among adults in Greece.
METHODS: This study involved 888 randomly identified adults (475 men and 413 women) aged > 35 years, and smokers of at least 100 cigarettes, in a population-based, multiregional, cross-sectional descriptive design. The selected individuals reflected the urban/rural population distribution in Greece and, within each study region, the age group and gender of the community setting. The diagnosis of COPD was based on clinical and spirometric data including reversibility test (DeltaFEV(1) < 15%).
RESULTS: The overall prevalence of COPD in the population aged > 35 years with a smoking history of > 100 cigarettes per lifetime was 8.4%. The gender-standardized COPD prevalence was 11.6% for men and 4.8% for women. The COPD prevalence by community setting was as follows: Athens, 6%; other urban areas, 10.1%; semiurban areas, 8.5%; and rural areas, 9.1%. Smoking intensity and age were significantly associated with higher COPD prevalence in both men and women.
CONCLUSIONS: COPD is a substantial health problem in Greece, although prevalence rates are lower than expected when the high smoking rates are taken into account. The high proportion of the patients with mild COPD who were unaware of their illness highlights the need to increase public awareness of COPD.

Entities:  

Mesh:

Year:  2004        PMID: 15006947     DOI: 10.1378/chest.125.3.892

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  43 in total

1.  Prevalence of obstructive lung disease in a general population sample: the NICECOPD study.

Authors:  Eoin Murtagh; Liam Heaney; Jenny Gingles; Richard Shepherd; Frank Kee; Chris Patterson; Joe MacMahon
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  An estimate of the burden of serious fungal diseases in Greece.

Authors:  M N Gamaletsou; M Drogari-Apiranthitou; D W Denning; N V Sipsas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-16       Impact factor: 3.267

3.  Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients.

Authors:  Athanasios Tselebis; Epaminondas Kosmas; Dionisios Bratis; Georgios Moussas; Athanasios Karkanias; Ioannis Ilias; Nikolaos Siafakas; Alexandros Vgontzas; Nikolaos Tzanakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-14       Impact factor: 3.455

4.  Prevalence of chronic diseases and morbidity in primary health care in central Greece: an epidemiological study.

Authors:  Markos Minas; Nikolaos Koukosias; Elias Zintzaras; Konstantinos Kostikas; Konstantinos I Gourgoulianis
Journal:  BMC Health Serv Res       Date:  2010-08-28       Impact factor: 2.655

5.  Body composition in severe refractory asthma: comparison with COPD patients and healthy smokers.

Authors:  Markos Minas; Andriana I Papaioannou; Agori Tsaroucha; Zoe Daniil; Chrissi Hatzoglou; Markos Sgantzos; Konstantinos I Gourgoulianis; Konstantinos Kostikas
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

6.  A discriminant function model as an alternative method to spirometry for COPD screening in primary care settings in China.

Authors:  Jiangyu Cui; Yumin Zhou; Jia Tian; Xinwang Wang; Jingping Zheng; Nanshan Zhong; Pixin Ran
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

7.  Two-year mortality of patients with COPD in primary health care: an observational study.

Authors:  Markos Minas; Ioanna Verrou-Katsarou; Parthena Mystridou; Eleni Apostolidou; Chrisi Hatzoglou; Konstantinos I Gourgoulianis
Journal:  Int J Gen Med       Date:  2012-10-05

8.  Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study.

Authors:  Nikolaos Tzanakis; Nikolaos Koulouris; Katerina Dimakou; Konstantinos Gourgoulianis; Epameinondas Kosmas; Georgia Chasapidou; Athanasios Konstantinidis; Christos Kyriakopoulos; Theodoros Kontakiotis; Aggeliki Rapti; Mina Gaga; Konstantinos Kalafatakis; Konstantinos Kostikas
Journal:  BMC Pulm Med       Date:  2021-07-09       Impact factor: 3.317

9.  MiR-221-3p and miR-92a-3p enhances smoking-induced inflammation in COPD.

Authors:  Yahui Shen; Huiyu Lu; Guixian Song
Journal:  J Clin Lab Anal       Date:  2021-06-07       Impact factor: 2.352

10.  COPD and disease-specific health status in a working population.

Authors:  Koichi Nishimura; Satoshi Mitsuma; Atsuko Kobayashi; Mikako Yanagida; Kazuhito Nakayasu; Yoshinori Hasegawa; Paul W Jones
Journal:  Respir Res       Date:  2013-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.